Brandon, FL USA - 01 Jan `21Evaluate the efficacy and safety of investigational medication


Official title: A Phase III, randomized, double blind, placebo controlled study to evaluate the efficacy and safety of AS012 in subjects with nonsegmental vitiligo

Ages eligible: 18 + years of age

Stipend: Receive compensation for your time and travel of up to $1,670

Location: Brandon, FL

Start Date: Jan 2021

Completion Date: (estimated) Dec 2021

Status: Recruiting

Contact: To learn more about this study, you or your doctor may contact Stanley Katz, MD at 813-948-7550 or visit website